Business Context and Reporting Period
This Form 8-K Current Report was filed by Northrop Grumman Corporation on September 15, 2009. The filing discloses significant changes in corporate leadership, specifically the announced retirement of the Chief Executive Officer and Chairman of the Board and the appointment of successors effective January 1, 2010.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements and personnel changes rather than financial performance data.
Material Changes
- Executive Departure: Ronald D. Sugar, CEO and Chairman, notified the Board of his intention to retire on June 30, 2010, and resign from his officer and director roles on December 31, 2009.
- Succession Plan: Wesley G. Bush, current President and Chief Operating Officer, was elected CEO and President effective January 1, 2010. He was also elected to the Board immediately.
- Board Leadership: Lewis W. Coleman, Lead Independent Director, was elected non-executive Chairman of the Board effective January 1, 2010.
Guidance, Outlook, and Compensation Details
Management commentary is limited to the transition plan and compensation terms for the departing CEO:
- Compensation: Dr. Sugar will receive his regular base salary through June 30, 2010, and is eligible for a 2009 bonus. He is not eligible for a 2010 bonus or new equity awards.
- Equity Vesting: All unvested stock options will vest upon his June 30, 2010 retirement. Other equity awards will be treated as retired if terms are more favorable than termination rules.
- Perquisites: Office and IT support will continue through December 31, 2014. A home security system will be provided through December 31, 2010.
- Severance: No severance payment will be made, consistent with company retirement policy.
Investor Verification Checklist
- Verify the exact effective dates for the resignation of Dr. Sugar (Dec 31, 2009) and the assumption of duties by Mr. Bush (Jan 1, 2010).
- Confirm the vesting schedule acceleration for Dr. Sugar's unvested stock options.
- Review the attached press release (Exhibit 99.2) for any additional strategic context regarding the leadership transition.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for fiscal metrics.